Proven Panel
This page updates as FDA acts. Follow the 503A track to get the decision in your inbox. Follow the 503A track
How peptides are regulated

Peptide status map

Where each peptide actually sits

Every compound in the library, placed in one of the four regulatory worlds. Filter by stage, then open the entry for the sourced detail. Placement describes status, not a recommendation.

Filter by stage

FDA-approved drug

Recognized 1 compound

Reviewed and approved by the FDA for a specific use. Legal, proven for that use, prescribed and pharmacy-dispensed.

Semaglutide
FDA-approved (Ozempic/Wegovy); bulk compounding excluded
Open entry

Compounding pathway

Case-by-case 2 compounds

In the 503A compounding process — nominated, in Category 1 or 2, or awaiting an FDA decision. Legal to compound is not the same as approved.

BPC-157
Under PCAC review (Jul 23, 2026); not yet on the 503A list
WADA-flagged Open entry
Thymosin Beta-4 TB-500
Under PCAC review (Jul 23, 2026); not yet on the 503A list
WADA-flagged Open entry

Gray-market "research chemical"

Caution 5 compounds

Sold "not for human use," outside FDA oversight of identity, purity, or dose. Where a peptide sits when it fits no other world — often permanently.

Copper Tripeptide-1 GHK-Cu ⚑ Provisional
Category 2 withdrawn (injectable); reported ~Feb 2027 review
Open entry
Thymosin Alpha-1 Tα1
Category 2 withdrawn; approved abroad (Zadaxin), not in the US
Open entry
CJC-1295
Category 2 nomination withdrawn; no active review
WADA-flagged Open entry
Ipamorelin
Category 2 (dual-listed); no active review
WADA-flagged Open entry
Melanotan II MT-II ⚑ Provisional
Illegal to sell; reported ~Feb 2027 review
Open entry

Sold as a supplement

Limited 1 compound

Marketed on supplement shelves, though most peptides do not legally qualify as dietary ingredients.

NAD+
Legal supplement (NMN/NR); IV NAD+ not FDA-approved
Open entry
Read carefully

A peptide sitting in the gray-market row isn’t “on its way” to approval — most will stay there. Being on this map doesn’t make anything legal to use, and dates marked provisional are trade reporting we haven’t confirmed against a primary FDA notice yet. Check each entry’s sources for the current status.